eCite Digital Repository
Does NLRP3 inflammasome and aryl hydrocarbon receptor play an interlinked role in bowel inflammation and colitis-associated colorectal cancer?
Citation
Ngui, IQH and Perera, AP and Eri, R, Does NLRP3 inflammasome and aryl hydrocarbon receptor play an interlinked role in bowel inflammation and colitis-associated colorectal cancer?, Molecules, 25, (10) pp. 1-25. ISSN 1420-3049 (2020) [Refereed Article]
 | PDF (Published version) 2Mb |
Copyright Statement
Copyright This is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited https://creativecommons.org/licenses/by/4.0/
DOI: doi:10.3390/molecules25102427
Abstract
Inflammation is a hallmark in many forms of cancer; with colitis-associated colorectal
cancer (CAC) being a progressive intestinal inflammation due to inflammatory bowel disease (IBD).
While this is an exemplification of the negatives of inflammation, it is just as crucial to have some
degree of the inflammatory process to maintain a healthy immune system. A pivotal component in
the maintenance of such intestinal homeostasis is the innate immunity component, inflammasomes.
Inflammasomes are large, cytosolic protein complexes formed following stimulation of microbial and
stress signals that lead to the expression of pro-inflammatory cytokines. The NOD-, LRR- and pyrin
domain-containing protein 3 (NLRP3) inflammasome has been extensively studied in part due to
its strong association with colitis and CAC. The aryl hydrocarbon receptor (AhR) has recently been
acknowledged for its connection to the immune system aside from its role as an environmental sensor.
AhR has been described to play a role in the inhibition of the NLRP3 inflammasome activation
pathway. This review will summarise the signalling pathways of both the NLRP3 inflammasome
and AhR; as well as new-found links between these two signalling pathways in intestinal immunity
and some potential therapeutic agents that have been found to take advantage of this link in the
treatment of colitis and CAC.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | aryl hydrocarbon receptor, NLRP3 inflammasome, colitis, colon cancer, NF-κB |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Oncology and carcinogenesis |
| Research Field: | Cancer diagnosis |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Ngui, IQH (Mr Ivan Ngui) |
| UTAS Author: | Perera, AP (Mrs Agampodi Perera) |
| UTAS Author: | Eri, R (Associate Professor Raj Eri) |
| ID Code: | 140407 |
| Year Published: | 2020 |
| Web of Science® Times Cited: | 3 |
| Deposited By: | Health Sciences |
| Deposited On: | 2020-08-14 |
| Last Modified: | 2021-04-20 |
| Downloads: | 7 View Download Statistics |
Repository Staff Only: item control page